Yanhui Yin

977 total citations
27 papers, 725 citations indexed

About

Yanhui Yin is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Yanhui Yin has authored 27 papers receiving a total of 725 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 16 papers in Molecular Biology and 11 papers in Oncology. Recurrent topics in Yanhui Yin's work include Immunotherapy and Immune Responses (14 papers), Immune Cell Function and Interaction (8 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Yanhui Yin is often cited by papers focused on Immunotherapy and Immune Responses (14 papers), Immune Cell Function and Interaction (8 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Yanhui Yin collaborates with scholars based in China, United States and Australia. Yanhui Yin's co-authors include Xuewen Pang, Weifeng Chen, Xue–Yuan Dong, Xiao Song, Jiaqing Hao, Yu Zhang, Xiaoping Qian, Jirun Peng, Bing Li and Q. Xing and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and The Journal of Immunology.

In The Last Decade

Yanhui Yin

27 papers receiving 713 citations

Peers

Yanhui Yin

IMMUN

ONCOL

PRM

Henrick Horita United States

Pu Zhang China

Yang Luo China

Suha Deen United Kingdom

Qianghua Hu United States

Rezina Arju United States

Markus Grubinger Austria

Anja Schramme Germany

Steven M. Bair United States

Diego Maritano Italy

Henrick Horita United States

Yanhui Yin

539 ×1.3

238 ×1.0

IMMUN

146 ×0.7

ONCOL

158 ×0.9

102 ×1.5

PRM

Citations per year, relative to Yanhui Yin Yanhui Yin (= 1×) peers Henrick Horita

Countries citing papers authored by Yanhui Yin

Since Specialization

Citations

This map shows the geographic impact of Yanhui Yin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanhui Yin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanhui Yin more than expected).

Fields of papers citing papers by Yanhui Yin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanhui Yin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanhui Yin. The network helps show where Yanhui Yin may publish in the future.

Co-authorship network of co-authors of Yanhui Yin

This figure shows the co-authorship network connecting the top 25 collaborators of Yanhui Yin. A scholar is included among the top collaborators of Yanhui Yin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanhui Yin. Yanhui Yin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Mo, et al.. (2024). Quantitative analysis of immune cells within the tumor microenvironment of glioblastoma and their relevance for prognosis. International Immunopharmacology. 142(Pt A). 113109–113109. 4 indexed citations

Yin, Yanhui, et al.. (2023). Immune micro-environment analysis and establishment of response prediction model for PD-1 blockade immunotherapy in glioblastoma based on transcriptome deconvolution. Journal of Cancer Research and Clinical Oncology. 149(13). 11689–11703. 4 indexed citations

Ma, Zihan, Chenfeng Mao, Xiao Chen, et al.. (2022). Peptide Vaccine Against ADAMTS-7 Ameliorates Atherosclerosis and Postinjury Neointima Hyperplasia. Circulation. 147(9). 728–742. 42 indexed citations

Wang, Ying, Xiao Song, Zeyu Liu, et al.. (2018). Cancer/testis Antigen MAGEA3 Interacts with STAT1 and Remodels the Tumor Microenvironment. International Journal of Medical Sciences. 15(14). 1702–1712. 14 indexed citations

Hao, Jiaqing, Yuwen Zhang, Xiaofang Yan, et al.. (2018). Circulating Adipose Fatty Acid Binding Protein Is a New Link Underlying Obesity-Associated Breast/Mammary Tumor Development. Cell Metabolism. 28(5). 689–705.e5. 114 indexed citations

Song, Xiao, et al.. (2018). Post-transcriptional regulation of cancer/testis antigen MAGEC2 expression by TRIM28 in tumor cells. BMC Cancer. 18(1). 971–971. 9 indexed citations

Sun, Xiaotong, Zhongtian Jin, Xiao Song, et al.. (2015). Evaluation of KIF23 variant 1 expression and relevance as a novel prognostic factor in patients with hepatocellular carcinoma. BMC Cancer. 15(1). 961–961. 46 indexed citations

Li, Xiaofeng, Jirun Peng, Yanli Pang, et al.. (2015). Identification of a FOXP3+CD3+CD56+ population with immunosuppressive function in cancer tissues of human hepatocellular carcinoma. Scientific Reports. 5(1). 14757–14757. 27 indexed citations

Huang, Jing, Wenwei Shao, Yanhui Yin, et al.. (2014). Cytokine-like Molecule CCDC134 Contributes to CD8+ T-cell Effector Functions in Cancer Immunotherapy. Cancer Research. 74(20). 5734–5745. 19 indexed citations

10.

Hao, Jiaqing, Rui Shen, Yan Li, Yu Zhang, & Yanhui Yin. (2014). Cancer–testis antigen HCA587/MAGE-C2 interacts with BS69 and promotes its degradation in the ubiquitin–proteasome pathway. Biochemical and Biophysical Research Communications. 449(4). 386–391. 12 indexed citations

11.

Chen, Juanjuan, et al.. (2012). Induction of HCA587-Specific Antitumor Immunity with HCA587 Protein Formulated with CpG and ISCOM in Mice. PLoS ONE. 7(10). e47219–e47219. 15 indexed citations

12.

Zhang, Lijie, Jirun Peng, Juanjuan Chen, et al.. (2011). Identification of promiscuous HLA‐DR‐restricted CD4⁺ T‐cell epitopes on the cancer‐testis antigen HCA587. Cancer Science. 102(8). 1455–1461. 13 indexed citations

13.

Wang, Wei, Qian Li, Jun Zhang, et al.. (2010). Hemokinin-1 Activates the MAPK Pathway and Enhances B Cell Proliferation and Antibody Production. The Journal of Immunology. 184(7). 3590–3597. 25 indexed citations

14.

Xing, Q., Xuewen Pang, Jirun Peng, et al.. (2008). Identification of new cytotoxic T-lymphocyte epitopes from cancer testis antigen HCA587. Biochemical and Biophysical Research Communications. 372(2). 331–335. 18 indexed citations

15.

Pang, Yanli, Jirun Peng, Xuewen Pang, et al.. (2008). The immunosuppressive tumor microenvironment in hepatocellular carcinoma. Cancer Immunology Immunotherapy. 58(6). 877–886. 44 indexed citations

16.

Dong, Xue–Yuan, Xuewen Pang, Q. Xing, et al.. (2008). The Specific Immune Response to Tumor Antigen CP1 and Its Correlation With Improved Survival in Colon Cancer Patients. Gastroenterology. 134(4). 998–1006. 40 indexed citations

17.

Tian, Chan, Dan Lv, Huan Qiao, et al.. (2007). TFDP3 inhibits E2F1-induced, p53-mediated apoptosis. Biochemical and Biophysical Research Communications. 361(1). 20–25. 22 indexed citations

18.

Qiao, Huan, Luisa Di Stefano, Chan Tian, et al.. (2006). Human TFDP3, a Novel DP Protein, Inhibits DNA Binding and Transactivation by E2F. Journal of Biological Chemistry. 282(1). 454–466. 27 indexed citations

19.

Li, Yunyan, Xue–Yuan Dong, Yanhui Yin, et al.. (2005). BJ-TSA-9, a Novel Human Tumor-Specific Gene, Has Potential as a Biomarker of Lung Cancer. Neoplasia. 7(12). 1073–1080. 65 indexed citations

20.

Dong, Xue–Yuan, Xuewen Pang, Songtao Yu, et al.. (2004). Identification of genes differentially expressed in human hepatocellular carcinoma by a modified suppression subtractive hybridization method. International Journal of Cancer. 112(2). 239–248. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact